Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Vitamin D, specifically 1alpha,25-Dihydroxyvitamin D [1alpha,25(OH)(2)D], shows potential in inhibiting prostate cancer cell growth and inducing differentiation.
• The enzyme 25-Hydroxyvitamin D-1alpha-hydroxylase [1alpha-OHase], crucial for 1alpha,25(OH)(2)D synthesis, is present in prostate cells.
• A notable decrease in 1alpha-OHase activity was observed in prostate cancer cells, suggesting a potential defect.

Purpose of the Study:

• To investigate if reduced 1alpha-OHase activity in prostate cancer is due to promoter-level dysregulation.
• To identify specific promoter regions of the 1alpha-OHase gene that influence its activity.

Main Methods:

• Synthesized a series of deletion constructs of the 1alpha-OHase promoter.
• Cloned these constructs upstream of a luciferase reporter gene.
• Transfected constructs into normal (PZHPV-7) and prostate cancer cell lines (PC-3, DU145, LNCaP) to assess promoter activity.

Main Results:

• Identified two regions (-1100 bp and -394 bp upstream of ATG) with high basal activity in normal prostate cells.
• Observed significantly lower basal promoter activity for both regions in PC-3 and DU145 cells compared to normal cells.
• Found a complete loss of promoter activity in the LNCaP cell line.

Conclusions:

• The decreased 1alpha-OHase enzyme activity in prostate cancer cells is likely caused by reduced promoter activity.
• This suggests a potential mechanism involving gene promoter dysregulation in the development or progression of prostate cancer.